I am exciting to publish our validated, lab-based model of oral gonorrhoea infection! With this model we can begin to understand how gonorrhoea behaves in the mouth (which is lacking) and screen for new compounds for interventions such as a gum to prevent infections. sti.bmj.com/content/earl...
06.10.2025 02:27 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
Our new review โ๐๐ฉ๐ฆ ๐๐ฆ๐ฏ๐ต๐ณ๐ข๐ญ ๐๐ฎ๐ฑ๐ฐ๐ณ๐ต๐ข๐ฏ๐ค๐ฆ ๐ฐ๐ง ๐๐ข๐ค๐ค๐ช๐ฏ๐ฆ๐ด ๐ต๐ฐ ๐๐ช๐ต๐ช๐จ๐ข๐ต๐ฆ ๐ต๐ฉ๐ฆ ๐๐ฉ๐ณ๐ฆ๐ข๐ต ๐ฐ๐ง ๐๐ฏ๐ต๐ช๐ฃ๐ช๐ฐ๐ต๐ช๐ค-๐๐ฆ๐ด๐ช๐ด๐ต๐ข๐ฏ๐ต ๐๐ข๐ค๐ต๐ฆ๐ณ๐ช๐ข๐ญ ๐๐ข๐ต๐ฉ๐ฐ๐จ๐ฆ๐ฏ๐ดโ is out
Compared to antibiotics, vaccines:
โ Act prophylactically at low pathogen burden
โ Less prone to inducing resistance due to multifactorial nature of immune pressure
๐งต1/3
23.08.2025 12:00 โ ๐ 31 ๐ 13 ๐ฌ 2 ๐ 2
Some NICUs donโt specifically cover anaerobes for NEC, although more to do with understanding of the developing GI microbiome. Your Q isnโt whether anaerobes are there, more what happens if we donโt go out of our way to treat them? There are some cholangitis & asp pneumonia studies ๐คทโโ๏ธ
22.08.2025 19:55 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0
๐ค could consider when clindamycin was abandoned for IAI (because rising Bacteroides-R). If this was preceded by โฌ๏ธ refractory cases that would be convincing-ish. And how about before any of these drugs were available? Anaerobic culture standards probably havenโt been consistent enough to be useful.
22.08.2025 19:55 โ ๐ 2 ๐ 0 ๐ฌ 1 ๐ 0
Exited to announce 2 EDCTP consortiums led @lshtm.bsky.social w partners in Europe & West, East & Southern Africa
MAMS4CL will deliver seamless Phase 2-3 trial of treatments for Cutaneous Leishmaniasis.
IVMKIDS will provide data on paediatric dosing ivermectin down to 5kg/weight for STH & Scabies.
21.08.2025 08:28 โ ๐ 6 ๐ 2 ๐ฌ 0 ๐ 0
Case report of osteomyelitis relapse after 50 years
pubmed.ncbi.nlm.nih.gov/10443871/
13.08.2025 17:41 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Phenomenal piece of work by a great team across @mrcunitgambia.bsky.social @lshtm.bsky.social @sheffielduni.bsky.social - Delighted to have played a small part in combining epidemiology & immunology to shed light on what protection for #StrepA might look like & help advance vaccine development.
08.08.2025 15:28 โ ๐ 6 ๐ 1 ๐ฌ 0 ๐ 0
Fantastic to see this immense body of excellent work published! Well done @alexjkeeley.bsky.social and everyone involved ๐
#StrepA
@floreyinstitute.bsky.social
@molmicrosheffield.bsky.social
08.08.2025 10:25 โ ๐ 5 ๐ 2 ๐ฌ 0 ๐ 0
VERY excited by our latest work on StrepA below, but also rhe multiple collaborations and work to come off the back of this at MRCG
08.08.2025 09:14 โ ๐ 10 ๐ 1 ๐ฌ 0 ๐ 0
๐งต Our paper out today in @naturemedicine.bsky.social
www.nature.com/articles/s41...
On development of #StrepA #Immunity over life course in #TheGambia raising hope for #vaccines on the horizon
1/
#Immunosky #IDsky #MicroSky #globalhealth.
08.08.2025 09:07 โ ๐ 33 ๐ 10 ๐ฌ 3 ๐ 5
Many, perhaps most, of the deaths from โnephropathiesโ (8%) and heart disease (12%) would have been infection-related so >2/3 deaths likely infection-related. Many, probably most, due to APSGN & RHD (i.e. #StrepA). Guess what? ๐บ๐ธ made a vaccine (it worked). ๐ needs to do it again.
13.07.2025 18:22 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
A Phaseย II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge - ...
Introduction Viral respiratory tract infections are of global concern, with an unmet need for a broad-spectrum antiviral prophylactic. HEX17, a multivalent carbohydrate-binding module, binds to sialic...
A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.
Kitson, G., Byford, M., Cass, L. et al.
Infect Dis Ther (2025).
doi.org/10.1007/s401...
02.07.2025 08:51 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0
Job Opportunity at LSHTM: Research Assistant
The London School of Hygiene & Tropical Medicine (LSHTM) is one of the worldโs leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working i...
Come & work with me @benvyle.bsky.social @lshtm.bsky.social & @thelovetankcic.bsky.social Research Assistant with funded PhD within multidisciplinary project on Syphilis & STI control in the UK. Working with us to understand stakeholder & community perspectives on novel STI control strategies
24.06.2025 15:27 โ ๐ 15 ๐ 13 ๐ฌ 1 ๐ 2
It becomes the Thesis of Theseus.
24.06.2025 10:32 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0
Read the latest Journal of #Infection for the Phase-IIa trial and how it evaluates the safety and pharmacokinetics of high-dose, 10 weekly subcutaneous injections of penicillin (#SCIP) in young people with a history of acute rheumatic fever (#ARF) ๐ www.journalofinfecti...
22.06.2025 09:16 โ ๐ 2 ๐ 3 ๐ฌ 1 ๐ 0
Antagonism as a foraging strategy in microbial communities
In natural habitats, nutrient availability limits bacterial growth. We discovered that bacteria can overcome this limitation by acquiring nutrients by lysing neighboring cells through contact-dependen...
๐ฐ๐
๐ด๐
๐พ๐ผ๐ด
Stubbusch et al ๐๐๐๐๐๐๐
Bacteria ๐ฆ repurpose Type VI Secretion Systems based on environmental cues:
Nutrient-rich environments โ kill competitors
Under starvation โ lyse neighbors to scavenge their nutrients
Even โnon-pathogensโ shift from competition to predation as a survival strategy
14.06.2025 04:37 โ ๐ 29 ๐ 12 ๐ฌ 2 ๐ 1
Last of the #LISSSD25 presentations is Prof Victor Nizet imploring the community to think like streptococci in these times of authoritarianism USA anti-science
๐ Evade host immunity (cont to do work)
๐ Form biofilms (network)
๐ Colonise diverse hosts (expand skill sets)
#strep #idsky
05.06.2025 04:03 โ ๐ 2 ๐ 2 ๐ฌ 2 ๐ 0
Patient Stories โ LISSSD 2025
I said no more #LISSSD25 posts but forgot a major highlight!
Most sessions started w/ a patient lived experience video, and you can see them all @ lisssd2025.org/patient-stories
Looking after patients during thier illnesses is v. stressful so it's great to hear their experiences when recovered.
05.06.2025 07:33 โ ๐ 4 ๐ 4 ๐ฌ 0 ๐ 0
Prof N Moreland from NZ speaks through the ARF perturbed immune response in ARF.
๐ All strep A serotypes assoc w/ ARF in NZ
๐ Increased IgG3 ab phenotpes
๐ Immune infiltration valves incl plasma cells.
๐ DIifferences in immue activation in acute & chronic RHD
#LISSSD25
04.06.2025 01:09 โ ๐ 5 ๐ 2 ๐ฌ 1 ๐ 0
Program Officer - Global Health R&D @openphil | views my own. Malaria researcher | R21 inventor
The Pediatric Infectious Disease Journalยฎ (PIDJ) is a complete, up-to-the-minute resource on #infectious #diseases in #children.COVID19:
https://journals.lww.com/pidj/pages/collectiondetails.aspx?TopicalCollectionId=19
Australiaโs largest child health research institute | Top 3 globally for paediatric research impact
Transforming child and adolescent health through world-class science, clinical innovation & global collaboration.
1,800+ researchers | Based in Melbourne
1Day Sooner leads campaigns in science, policy, and bioethics to stop the worldโs most harmful infectious diseases. We advocate for volunteers who participate in high-impact medical studies, including human challenge studies. www.1daysooner.org
Emergency physician & Dean of the Yale School of Public Health. Gun violence prevention researcher. Incorrigible optimist (because we can and do create change, together). Mom of two teens. GO BILLS. @meganranney at the other place ๐๐ฉบ๐๐๐งช
A platform for projects related to David Graeberโs legacy, developing his ideas and projects that will take on a life of their own, continuing and contributing to his work.
https://davidgraeber.institute
With support of the Leducq Foundation, the iSPY Explore Network, led by UC San Diego in partnership with Imperial College London (iSpy Life), unites 14 investigators from the USA, Australia, Brazil, and New Zealand to understand streptococcal immunity.
iSpy LIFE: Taking on Streptococcus pyogenes (Strep A)! Uniting 28 researchers from 11 nations. Led by Imperial College London & University of California San Diego. Funded by Leducq Foundation. Follow us for updates!
#iSpyLIFE #StrepA #Streptococcus
Paediatrician | Immunology | Vaccines | Infectious Diseases
Deputy Head of Paediatrics
Clinical Scientist in Paediatric Infectious Diseases
University of Fribourg
The University of Melbourne
Professor โข clinician โข scientistโข hiker
Paediatrics โข infectious diseases โข TB
@University Childrens Hospital Basel #UKBB
@Children's Hospital of Central Switzerland #KidZ
https://www.luks.ch/spezialisten/prof-dr-med-nicole-ritz
https://www.ccha.ch/en/
Scientific Lead - Pathogen Immunology at UKHSA Porton.
Microbial Immunology, Correlates of Protection, Functional serology, Vaccines for AMR, Mucosal Immunity, Strain Variation, Biofilms, Complement
*opinions my own and not representative of UKHSA
Professor of Microbiology and Immunology at the University of Western Ontario - we study bacterial exotoxins from Strep. pyogenes and Staph. aureus and how these pathogens manipulate our immune system. mccormicklab.ca
Computational biologist @MCRI | Naarm Melbourne
Center for Food Allergy Research | National Allergy Centre of Excellence | #WomenInSTEM ๐ง๐ปโ๐ฌ
Postdoctoral fellow working on treatments for food allergies ๐ฅ
#scRNAseq #systemsbiology
Views are my own
Infection and Immunity | Vaccines and Antibodies | Strep A and rheumatic fever | Research scientist and Associate Professor in Aotearoa New Zealand
Infectious diseases doctor. Immunologist. Vaccine researcher & advocate. https://profiles.imperial.ac.uk/c.chiu